BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28593747)

  • 21. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
    Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A metabolomic approach to lung cancer.
    Hori S; Nishiumi S; Kobayashi K; Shinohara M; Hatakeyama Y; Kotani Y; Hatano N; Maniwa Y; Nishio W; Bamba T; Fukusaki E; Azuma T; Takenawa T; Nishimura Y; Yoshida M
    Lung Cancer; 2011 Nov; 74(2):284-92. PubMed ID: 21411176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
    Alberg AJ; Gordon GB; Genkinger JM; Hoffman SC; Selvin E; Comstock GW; Helzlsouer KJ
    Anticancer Res; 2001; 21(6A):4051-4. PubMed ID: 11911290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.
    Osman D; Ali O; Obada M; El-Mezayen H; El-Said H
    Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27862090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study.
    Roś-Mazurczyk M; Wojakowska A; Marczak Ł; Polański K; Pietrowska M; Polanska J; Dziadziuszko R; Jassem J; Rzyman W; Widlak P
    Acta Biochim Pol; 2017; 64(3):513-518. PubMed ID: 28803255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of serum amino acid profiles' utility in non-small cell lung cancer detection in Polish population.
    Klupczynska A; Dereziński P; Dyszkiewicz W; Pawlak K; Kasprzyk M; Kokot ZJ
    Lung Cancer; 2016 Oct; 100():71-76. PubMed ID: 27597283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
    Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
    Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
    Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
    Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
    Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
    Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of CD24 in nonmelanoma skin cancer.
    Miller E; Shapira S; Gur E; Naumov I; Kazanov D; Leshem D; Barnea Y; Meshiach Y; Gat A; Sion D; Arber N; Kraus S
    Int J Biol Markers; 2012 Dec; 27(4):e331-6. PubMed ID: 23250778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
    Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
    Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients.
    Boguszewicz Ł; Bieleń A; Mrochem-Kwarciak J; Skorupa A; Ciszek M; Heyda A; Wygoda A; Kotylak A; Składowski K; Sokół M
    Metabolomics; 2019 Aug; 15(8):110. PubMed ID: 31420744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.